Spyre Therapeutics, Inc.

JANE STREET GROUP, LLC SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

54,278

Value ($000)

24

Weight

0.0%

2020 Q2 - 2023 Q2 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	24	0.0%	54,278	6/30/2023
2023 Q1	5/16/2023	12	0.0%	42,763	3/31/2023
2020 Q3	11/17/2020	84	0.0%	11,881	9/30/2020
2020 Q2	8/17/2020	115	0.0%	12,484	6/30/2020